Kasamu Dawa Kabiru

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.

J. Barrett, M. Tremelling, M. Parkes, 2019, Gastroenterology.